Yanwen Lu
No. 321 Zhongshan Road
Nanjing, 210008, China
Nanjing, 210008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
TFE3 fusion proteins promote the progression of TFE3 rearranged renal cell carcinoma via enhancing chaperone-mediated lipophagy.
Journal: Cell communication and signaling : CCS
Published: November 13, 2024
LncRNA like NMRK2 mRNA functions as a key molecular scaffold to enhance mitochondrial respiration of NONO-TFE3 rearranged renal cell carcinoma in an NAD+ kinase-independent manner.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 05, 2023
Identification of an immunogenic cell death-related gene signature predicts survival and sensitivity to immunotherapy in clear cell renal carcinoma.
Journal: Scientific reports
Published: November 21, 2022
Estrogen associates with female predominance in Xp11.2 translocation renal cell carcinoma.
Journal: Scientific reports
Published: November 15, 2022
High VSX1 expression promotes the aggressiveness of clear cell renal cell carcinoma by transcriptionally regulating FKBP10.
Journal: Journal of translational medicine
Published: July 22, 2022
Low expression of PEBP1P2 promotes metastasis of clear cell renal cell carcinoma by post-transcriptional regulation of PEBP1 and KLF13 mRNA.
Journal: Experimental hematology & oncology
Published: June 28, 2022
Up-regulation of NMRK2 mediated by TFE3 fusions is the key for energy metabolism adaption of Xp11.2 translocation renal cell carcinoma.
Journal: Cancer letters
Published: January 12, 2022
Contrast-Enhanced Ultrasound Features of Adult Xp11.2 Translocation Renal Cell Carcinoma: Differential Diagnosis With Three Main Renal Cell Carcinoma Subtypes.
Journal: Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
Published: October 16, 2021
CircMET promotes tumor proliferation by enhancing CDKN2A mRNA decay and upregulating SMAD3.
Journal: Molecular cancer
Published: October 16, 2021
Both SUMOylation and ubiquitination of TFE3 fusion protein regulated by androgen receptor are the potential target in the therapy of Xp11.2 translocation renal cell carcinoma.
Journal: Clinical and translational medicine
Published: September 16, 2021
Estradiol increases risk of topoisomerase IIβ-mediated DNA strand breaks to initiate Xp11.2 translocation renal cell carcinoma.
Journal: Cell communication and signaling : CCS
Published: May 25, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026